AnteoTech Limited engages in developing, commercializing, manufacturing, and distributing products for the life sciences research, in-vitro diagnostics, energy, and medical device markets primarily in Australia. Its principal technology products include AnteoCoat, which is applicable to the energy sector in lithium-ion batteries; AnteoBind that is applicable to point of care, in vitro, and life science diagnostic sectors; and AnteoRelease, which is applicable in the medical technology sector comprising implants for infectious diseases. The company also manufactures and sells in vitro diagnostic tests. AnteoTech Limited has collaboration agreements with Sona Nanotech Inc. to co-develop new products that have the potential to speed up the development and improve the performance of lateral flow immunoassays; Lumos Diagnostics for the development of assays; and Merck to co-develop AnteoBind activated Europium particles for point of care diagnostic testing market. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.